GLYBURIDE Side Effects

6374704-8 | Hypercapnia, Hypoglycaemia, Respiratory Failure, Vomiting
on Sep 15, 2009 Male patient from UNITED STATES , 57 years of age, weighting 526.3 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypercapnia, hypoglycaemia, respiratory failure, vomiting. Glyburide dosage: 2.5 Mg Every Day Po. Patient was hospitalized.

6370625-5 | Hypoglycaemia
Patient was taking Glyburide (View Usage). Patient had the following side effects: hypoglycaemia on Sep 21, 2009 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 359.4 lb, was diagnosed with diabetes mellitus and. Glyburide dosage: 2.5 Mg Am Po. Patient was hospitalized.

6369798-X | Hyperbilirubinaemia Neonatal
Adverse event was reported on Sep 22, 2009 by a Male patient taking Glyburide (View Usage) (Dosage: ) was diagnosed with gestational diabetes and. Location: UNITED STATES , weighting 7.50 lb, After Glyburide was administered, patient had the following side effects: hyperbilirubinaemia neonatal. Patient was hospitalized.

6330236-4 | Blood Glucose Decreased, Depressed Level Of Consciousness, Hyperglycaemia, Snoring, Somnolence, Unresponsive To Stimuli
on Aug 26, 2009 Female patient from UNITED STATES , 91 years of age, was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, depressed level of consciousness, hyperglycaemia, snoring (What is snoring?), somnolence, unresponsive to stimuli. Glyburide dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ).


6318352-4 | Hypoglycaemia, Renal Failure Acute, Syncope
on Aug 20, 2009 Male patient from UNITED STATES , 59 years of age, weighting 237.7 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient had the following side effects: hypoglycaemia, renal failure acute, syncope. Glyburide dosage: 10mg Bid Po. During the same period patient was treated with METFORMIN HCL (1000mg Bid Po) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6315702-X | Abnormal Behaviour, Blood Glucose Fluctuation, Pulmonary Embolism, Screaming, Thrombosis, Typhoid Fever
Patient was taking Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: abnormal behaviour, blood glucose fluctuation, pulmonary embolism (What is pulmonary embolism?), screaming, thrombosis, typhoid fever on Aug 03, 2009 from UNITED STATES Additional patient health information: Female patient , 84 years of age, . Glyburide dosage: . During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), VIOXX (View Vioxx Review and Vioxx Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6313645-9 | Aplastic Anaemia, Cytomegalovirus Infection, Dizziness, Dyspnoea, Epstein-barr Virus Infection, Fatigue, Hearing Impaired, Hepatitis, Hiv Infection
Adverse event was reported on Aug 17, 2009 by a Male patient taking Glyburide (View Usage) (Dosage: 5mg Bid Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 58 years of age, Patient experienced the following unwanted or unexpected effects: aplastic anaemia, cytomegalovirus infection (What is cytomegalovirus infection?), dizziness (What is dizziness?), dyspnoea, epstein-barr virus infection, fatigue, hearing impaired, hepatitis (What is hepatitis?), hiv infection (What is hiv infection?).

6310394-8 | Agitation, Blood Glucose Decreased, Crying, Eye Movement Disorder, Headache, Heart Rate Increased, Lethargy, Mobility Decreased
on Jul 28, 2009 Female patient from UNITED STATES , child 6 years of age, was treated with Glyburide (View Usage). Patient had the following side effects: agitation, blood glucose decreased, crying, eye movement disorder, headache (What is headache?), heart rate increased, lethargy, mobility decreased. Glyburide dosage: . Patient was hospitalized.

6303863-8 | Hypoglycaemia, Syncope
on Aug 07, 2009 Male patient from UNITED STATES , 60 years of age, weighting 196.4 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hypoglycaemia, syncope. Glyburide dosage: 7.5 Mg Bid Po. Patient was hospitalized.

6296729-3 | Antinuclear Antibody Positive, Myalgia, Rheumatoid Arthritis
Patient was taking Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: antinuclear antibody positive, myalgia, rheumatoid arthritis (What is rheumatoid arthritis?) on Jul 27, 2009 from FRANCE Additional patient health information: Male patient , 71 years of age, . Glyburide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6295320-2 | Hypoglycaemic Encephalopathy
Adverse event was reported on Jul 29, 2009 by a Female patient taking Glyburide (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: JAPAN , 94 years of age, Patient had the following side effects: hypoglycaemic encephalopathy.

6282747-8 | Hypoglycaemia, Unresponsive To Stimuli
on Jul 22, 2009 Male patient from UNITED STATES , 86 years of age, weighting 166.0 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hypoglycaemia, unresponsive to stimuli. Glyburide dosage: 10 Mg Am Po. Patient was hospitalized.

6276205-4 | Hypoglycaemia
on Jul 20, 2009 Male patient from UNITED STATES , 58 years of age, weighting 200.0 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Glyburide dosage: 5 Mg Everyday Po. Patient was hospitalized.

6274549-3 | Hypoglycaemia, Visual Impairment
Patient was taking Glyburide (View Usage). Patient had the following side effects: hypoglycaemia, visual impairment on Feb 23, 2009 from JAPAN Additional patient health information: Male patient , 48 years of age, weighting 154.3 lb, was diagnosed with diabetes mellitus, hyperglycaemia and. Glyburide dosage: .

6272480-0 | Blood Glucose Increased, Lactic Acidosis, Therapeutic Agent Toxicity
Adverse event was reported on Jan 18, 2007 by a Male patient taking Glyburide (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, After Glyburide was administered, patient had the following side effects: blood glucose increased, lactic acidosis, therapeutic agent toxicity. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ). Patient was hospitalized.

6271362-8 | Hypoglycaemia
on Jul 15, 2009 Male patient from UNITED STATES , 50 years of age, weighting 345.5 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Glyburide dosage: 5 Mg Every Day Po. Patient was hospitalized.

6259208-5 | Metabolic Acidosis, Renal Failure
on Jun 25, 2009 Female patient from , 82 years of age, weighting 127.9 lb, was treated with Glyburide (View Usage). Patient had the following side effects: metabolic acidosis, renal failure. Glyburide dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), UMULINE /00646003/ (View Umuline /00646003/ Review and Umuline /00646003/ Label ), CATAPRESSAN /00171101/ (View Catapressan /00171101/ Review and Catapressan /00171101/ Label ), ZESTRIL (View Zestril Review and Zestril Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

6248697-8 | Stevens-johnson Syndrome
Patient was taking Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: stevens-johnson syndrome on Jun 25, 2009 from UNITED STATES Additional patient health information: Male patient , 84 years of age, was diagnosed with diabetes mellitus and. Glyburide dosage: . During the same period patient was treated with METFORMIN HCL (500 Mg Bid Po) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6232228-2 | Muscle Spasms
Adverse event was reported on Jun 16, 2009 by a Female patient taking Glyburide (View Usage) (Dosage: Glyburide 1.25mg Bid Oral) was diagnosed with hyperlipidaemia, type 2 diabetes mellitus and. Location: UNITED STATES , weighting 218.0 lb, Patient experienced the following unwanted or unexpected effects: muscle spasms.

6231679-X | Hospitalisation, Loss Of Consciousness
on Jun 03, 2009 Male patient from UNITED STATES , 59 years of age, was treated with Glyburide (View Usage). Patient had the following side effects: hospitalisation, loss of consciousness. Glyburide dosage: Dose: Unk. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6222954-3 | Hospitalisation, Loss Of Consciousness
on Jun 03, 2009 Male patient from UNITED STATES , 59 years of age, was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hospitalisation, loss of consciousness. Glyburide dosage: Dose: Unk. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6168686-1 | Hypoglycaemia, Unresponsive To Stimuli
Patient was taking Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, unresponsive to stimuli on Apr 24, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 181.9 lb, was diagnosed with diabetes mellitus and. Glyburide dosage: 5 Mg Every Day Po. Patient was hospitalized.

6163741-4 | Hypoglycaemia
Adverse event was reported on Apr 20, 2009 by a Female patient taking Glyburide (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 60 years of age, weighting 200.0 lb, Patient had the following side effects: hypoglycaemia. During the same period patient was treated with FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CELEBREX (View Celebrex Review and Celebrex Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6133871-1 | Hypoglycaemia, Renal Failure Acute
on Mar 09, 2009 Female patient from GERMANY , 77 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, renal impairment and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hypoglycaemia, renal failure acute. Glyburide dosage: 1.75 Mg;daily;oral. During the same period patient was treated with LISINOPRIL (10 Mg;daily;oral) (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (500 Mg;twice A Day; Oral) (View Metformin Hcl Review and Metformin Hcl Label ), METOPROLOL TARTRATE (100 Mg;twice A Day;oral) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FUROSEMIDE (60 Mg;daily, Oral) (View Furosemide Review and Furosemide Label ), ASS (CON.) (View Ass (con.) Review and Ass (con.) Label ), PANTOZOL (CON.) (View Pantozol (con.) Review and Pantozol (con.) Label ), XIPAMIDE (CON.) (View Xipamide (con.) Review and Xipamide (con.) Label ). Patient was hospitalized.

6132567-X | Hypoglycaemia, Renal Failure Acute
on Mar 09, 2009 Female patient from GERMANY , 77 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, renal impairment and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, renal failure acute. Glyburide dosage: 1.75 Mg;daily;oral. During the same period patient was treated with LISINOPRIL (10 Mg;daily;oral) (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (500 Mg;twice A Day;oral) (View Metformin Hcl Review and Metformin Hcl Label ), METOPROLOL TARTRATE (100 Mg;twice A Day;oral) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FURORESE (FUROSEMIDE) (60 Mg;daily;oral) (View Furorese (furosemide) Review and Furorese (furosemide) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ). Patient was hospitalized.

6123648-5 | Hypoglycaemia
Patient was taking Glyburide (View Usage). Patient had the following side effects: hypoglycaemia on Mar 18, 2009 from UNITED STATES Additional patient health information: Male patient , 41 years of age, . Glyburide dosage: 125 Mg Bid Po.

6121750-5 | Confusional State, Hypoglycaemia, Vitamin B12 Deficiency
Adverse event was reported on Mar 13, 2009 by a Male patient taking Glyburide (View Usage) (Dosage: 10 Mg Bid Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 42 years of age, After Glyburide was administered, patient had the following side effects: confusional state, hypoglycaemia, vitamin b12 deficiency. During the same period patient was treated with METFORMIN HCL (500 Mg Bid Po) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6115441-4 | Confusional State, Hemiparesis, Hypoglycaemia
on Mar 05, 2009 Female patient from , 88 years of age, was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, hemiparesis, hypoglycaemia. Glyburide dosage: . During the same period patient was treated with METFORMINE ALTER (View Metformine Alter Review and Metformine Alter Label ), IKOREL (View Ikorel Review and Ikorel Label ), SOTALEX (View Sotalex Review and Sotalex Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), APROVEL (View Aprovel Review and Aprovel Label ).

6112414-2 | Blood Glucose Increased, Confusional State, Contrast Media Reaction, Hypoglycaemia, Lethargy, Nephropathy, Syncope
on Mar 11, 2009 Female patient from UNITED STATES , 74 years of age, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient had the following side effects: blood glucose increased, confusional state, contrast media reaction, hypoglycaemia, lethargy, nephropathy, syncope. Glyburide dosage: 2.5 Mg Every Day Po. Patient was hospitalized.

6109337-1 | Rash
Patient was taking Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: rash (What is rash?) on Mar 09, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 200.4 lb, . Glyburide dosage: 5 Mg Tablet 7.5 Mg Qd Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BETAMETHASONE VALERATE (View Betamethasone Valerate Review and Betamethasone Valerate Label ), METOPROLOL SUCCINATE EXTENDED RELEASE (View Metoprolol Succinate Extended Release Review and Metoprolol Succinate Extended Release Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), REQUIP (View Requip Review and Requip Label ), REQUIP XL (ROPINIROLE EXTENDED RELEASE) (View Requip Xl (ropinirole Extended Release) Review and Requip Xl (ropinirole Extended Release) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SINEMET (CARBIDOPA/LEVODOPA CONTROLLED RELEASE) (View Sinemet (carbidopa/levodopa Controlled Release) Review and Sinemet (carbidopa/levodopa Controlled Release) Label ).

6102210-4 | Stent Placement
Adverse event was reported on Mar 03, 2009 by a Male patient taking Glyburide (View Usage) (Dosage: ) . Location: UNITED STATES , 87 years of age, weighting 171.0 lb, Patient experienced the following unwanted or unexpected effects: stent placement. Patient was hospitalized.

6099403-1 | Dysphagia, Hyperglycaemia, Treatment Noncompliance
on Feb 26, 2009 Male patient from UNITED STATES , 66 years of age, weighting 152.0 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient had the following side effects: dysphagia, hyperglycaemia, treatment noncompliance. Glyburide dosage: Everyday Po. During the same period patient was treated with METFORMIN HCL (1000 Mg Bid Po) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6099394-3 | Hypoglycaemia, Loss Of Consciousness, Pallor, Syncope, Tremor
on Feb 26, 2009 Male patient from UNITED STATES , 79 years of age, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hypoglycaemia, loss of consciousness, pallor, syncope, tremor. Glyburide dosage: 2.5 Mg Everyday Po. Patient was hospitalized.

6087402-5 | Diabetes Mellitus Inadequate Control
Patient was taking Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control on Feb 19, 2009 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 188.0 lb, was diagnosed with diabetes mellitus and. Glyburide dosage: 5 Mg Bid Bid.

6085626-4 | Haemolytic Anaemia, Neoplasm Malignant, Neutropenia, Renal Failure, Transplant Rejection, Zygomycosis
Adverse event was reported on Feb 05, 2009 by a Male patient taking Glyburide (View Usage) (Dosage: Dose: Unk) . Location: UNITED STATES , 40 years of age, Patient had the following side effects: haemolytic anaemia, neoplasm malignant, neutropenia, renal failure, transplant rejection, zygomycosis. During the same period patient was treated with RIBAVIRIN (Dose: 200-1200) (View Ribavirin Review and Ribavirin Label ), EPOGEN (Dose: Unk) (View Epogen Review and Epogen Label ), INTERFERON ALFA 2B (Dose: 1.5-3.0 Million) (View Interferon Alfa-2b Review and Interferon Alfa-2b Label ), CYCLOSPORINE (Dose: Unk) (View Cyclosporine Review and Cyclosporine Label ), SIROLIMUS (Dose: Unk) (View Sirolimus Review and Sirolimus Label ), PREDNISONE (Dose: Unk) (View Prednisone Review and Prednisone Label ), FILGRASTIM (Dose: Unk) (View Filgrastim Review and Filgrastim Label ), AMPHOTERICIN B (Dose: Unk) (View Amphotericin B Review and Amphotericin B Label ).

6060971-7 | Hypoglycaemia
on Jan 29, 2009 Female patient from UNITED STATES , weighting 123.3 lb, was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hypoglycaemia. Glyburide dosage: 5mg Tablet 2.5 Mg Bid Oral. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), COREG (View Coreg Review and Coreg Label ), COUMADIN (View Coumadin Review and Coumadin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), IMDUR ER (ISOSORBIDE MONONITRATE (5K)) (View Imdur Er (isosorbide Mononitrate (5k)) Review and Imdur Er (isosorbide Mononitrate (5k)) Label ), LASIX (View Lasix Review and Lasix Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6051965-6 | Cardiac Arrest, Ventricular Fibrillation
on Jan 12, 2009 Male patient from UNITED STATES , 71 years of age, was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), ventricular fibrillation. Glyburide dosage: Dose: Unk. During the same period patient was treated with VITAMIN K (Dose: 0.5 Mg Parenteral) (View Vitamin K Review and Vitamin K Label ), COUMADIN (Dose: Unk) (View Coumadin Review and Coumadin Label ), SPIRONOLACTONE (Dose: Unk) (View Spironolactone Review and Spironolactone Label ), IRON (NOS) (Dose: Unk) (View Iron (nos) Review and Iron (nos) Label ), ERYTHROMYCIN (Dose: Unk) (View Erythromycin Review and Erythromycin Label ).

6035565-X | Asthenia, Fall, Hypoglycaemia, Renal Impairment
Patient was taking Glyburide (View Usage). Patient had the following side effects: asthenia, fall (What is fall?), hypoglycaemia, renal impairment on Jan 12, 2009 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 266.3 lb, was diagnosed with diabetes mellitus and. Glyburide dosage: 10 Mg Bid Po. Patient was hospitalized.

6000116-2 | Hypoglycaemia
Adverse event was reported on Dec 11, 2008 by a Male patient taking Glyburide (View Usage) (Dosage: 5 Mg Bid Po (duration: 5 Doses)) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 63 years of age, After Glyburide was administered, patient had the following side effects: hypoglycaemia. Patient was hospitalized and became disabled.

5990007-5 | Oedema Peripheral, Rash, Weight Increased
on Dec 09, 2008 Female patient from UNITED STATES , 82 years of age, weighting 130.0 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral, rash (What is rash?), weight increased. Glyburide dosage: 1.25 Once A Day.

5965308-7 | Hypoglycaemia
on Nov 22, 2008 Male patient from UNITED STATES , 79 years of age, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient had the following side effects: hypoglycaemia. Glyburide dosage: 2.5 Mg Every Day Po. Patient was hospitalized.

5961656-5 | Hypoglycaemic Encephalopathy
Patient was taking Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hypoglycaemic encephalopathy on Nov 13, 2008 from JAPAN Additional patient health information: Female patient , 82 years of age, was diagnosed with type 2 diabetes mellitus and. Glyburide dosage: . During the same period patient was treated with VOGLIBOSE (View Voglibose Review and Voglibose Label ). Patient was hospitalized and became disabled.

5960051-2 | Blood Glucose Decreased, Disorientation
Adverse event was reported on Nov 19, 2008 by a Male patient taking Glyburide (View Usage) (Dosage: 2.5mg Po Daily) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 222.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose decreased, disorientation. During the same period patient was treated with INSULIN ASPART (3 Units Sq W/meals) (View Insulin Aspart Review and Insulin Aspart Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), MOM (View Mom Review and Mom Label ), PERCOCET (View Percocet Review and Percocet Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5956655-3 | Hypoglycaemia
on Nov 17, 2008 Male patient from UNITED STATES , 54 years of age, weighting 154.3 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient had the following side effects: hypoglycaemia. Glyburide dosage: 10 Mg Bid Po. Patient was hospitalized.

5956585-7 | Hypoglycaemia, Hypophagia, Sepsis, Treatment Noncompliance
on Nov 17, 2008 Male patient from UNITED STATES , 83 years of age, weighting 216.9 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hypoglycaemia, hypophagia, sepsis (What is sepsis?), treatment noncompliance. Glyburide dosage: 7.5 Mg Every Day Po. Patient was hospitalized.

5955352-8 | Hypoglycaemia, Mental Status Changes, Treatment Noncompliance
Patient was taking Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, mental status changes, treatment noncompliance on Nov 13, 2008 from UNITED STATES Additional patient health information: Male patient , 84 years of age, weighting 125.9 lb, was diagnosed with diabetes mellitus and. Glyburide dosage: 10 Mg Bid Po. During the same period patient was treated with METFORMIN HCL (2500 Mg Every Day Po) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5951526-0 | Gastrointestinal Haemorrhage, Lymphoma, Renal Failure
Adverse event was reported on Nov 03, 2008 by a Male patient taking Glyburide (View Usage) (Dosage: ) . Location: MEXICO , 66 years of age, Patient had the following side effects: gastrointestinal haemorrhage, lymphoma (What is lymphoma?), renal failure. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), ASCRIPTIN /00058201/ (View Ascriptin /00058201/ Review and Ascriptin /00058201/ Label ). Patient was hospitalized.

5934048-2 | Confusional State, Hypoglycaemia, Lethargy
on Oct 28, 2008 Male patient from UNITED STATES , 80 years of age, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: confusional state, hypoglycaemia, lethargy. Glyburide dosage: 5 Mg Bid Po. Patient was hospitalized.

5926945-9 | Hypoglycaemia, Incorrect Dose Administered
on Oct 21, 2008 Male patient from UNITED STATES , 65 years of age, weighting 197.5 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, incorrect dose administered. Glyburide dosage: 10 Mg Bid Po. Patient was hospitalized.

5925832-X | Convulsion, Hypoglycaemia
Patient was taking Glyburide (View Usage). Patient had the following side effects: convulsion, hypoglycaemia on Oct 08, 2008 from CANADA Additional patient health information: Male patient , 63 years of age, was diagnosed with coronary artery disease (What is coronary artery disease?), angina pectoris, hypertension and. Glyburide dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), COVERSYL /00790701/ (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ). Patient was hospitalized.